Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-17-000266
Filing Date
2017-03-31
Accepted
2017-03-31 16:21:29
Documents
2
Group Members
ORBIMED ISRAEL GP LTD.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 ss37200_sc13da.htm SC 13D/A 87049
2 ss37200_ex99a.htm EX-99.A 13598
  Complete submission text file 0000947871-17-000266.txt   102243
Mailing Address 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 1022-4629
Business Address 89 MEDINAT HAYEHUDIM STREET, 11TH FLOOR HERZLIYA L3 46766 212-739-6400
OrbiMed Israel BioFund GP Limited Partnership (Filed by) CIK: 0001569821 (see all company filings)

EIN.: 980697985 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address BUILDING 7A, OMER INDUSTRIAL PARK POB 3030 OMER L3 8496500
Business Address BUILDING 7A, OMER INDUSTRIAL PARK POB 3030 OMER L3 8496500 972722602211
Medigus Ltd. (Subject) CIK: 0001618500 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88932 | Film No.: 17730665
SIC: 3841 Surgical & Medical Instruments & Apparatus